HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Sallouha Gabbouj Selected Research

Cadherins (E-Cadherin)

11/2016E-cadherin genetic variants predict survival outcome in breast cancer patients.
9/2010A single nucleotide polymorphism in the E-cadherin gene promoter -160 C/A is associated with risk of nasopharyngeal cancer.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Sallouha Gabbouj Research Topics

Disease

11Neoplasms (Cancer)
01/2022 - 09/2007
11Nasopharyngeal Carcinoma
10/2021 - 02/2006
5Breast Neoplasms (Breast Cancer)
11/2016 - 04/2008
2Disease Progression
01/2022 - 05/2011
2Liver Cirrhosis (Hepatic Cirrhosis)
06/2011 - 04/2009
2Hepatitis C
06/2011 - 04/2009
2Chronic Hepatitis C
06/2011 - 04/2009
2Neoplasm Metastasis (Metastasis)
03/2011 - 09/2007
1Uterine Cervicitis (Cervicitis)
01/2022
1Squamous Cell Carcinoma (Epidermoid Carcinoma)
01/2022
1Squamous Intraepithelial Lesions
01/2022
1Uterine Cervical Neoplasms (Cancer of the Cervix)
01/2022
1Triple Negative Breast Neoplasms
11/2019
1Fibrosis (Cirrhosis)
06/2011
1Nasopharyngeal Neoplasms (Cancer of the Nasopharynx)
09/2010
1Infections
04/2009
1Chronic Hepatitis (Chronic Active Hepatitis)
04/2009
1Hepatocellular Carcinoma (Hepatoma)
04/2009

Drug/Important Bio-Agent (IBA)

5Genetic Markers (Genetic Marker)IBA
10/2012 - 09/2007
4EnzymesIBA
01/2022 - 04/2008
2DNA (Deoxyribonucleic Acid)IBA
11/2016 - 05/2011
2Cadherins (E-Cadherin)IBA
11/2016 - 09/2010
2HLA Antigens (Human Leukocyte Antigens)IBA
08/2011 - 02/2011
2CytokinesIBA
06/2011 - 04/2009
2Interleukin-10 (Interleukin 10)IBA
06/2011 - 04/2009
2Interleukin-18 (Interleukin 18)IBA
06/2011 - 08/2008
1Messenger RNA (mRNA)IBA
01/2022
1ArginaseIBA
01/2022
1Protein Isoforms (Isoforms)IBA
01/2022
1Glutathione PeroxidaseIBA
10/2021
1Codon (Codons)IBA
10/2021
1Progesterone Receptors (Progesterone Receptor)IBA
11/2019
1Epidermal Growth Factor (EGF)IBA
11/2019
1Estrogens (Estrogen)FDA Link
11/2019
1Nitric Oxide Synthase (NO Synthase)IBA
04/2019
1Indoleamine-Pyrrole 2,3,-Dioxygenase (Indoleamine 2,3 Dioxygenase)IBA
01/2016
1P-2 (P 2)IBA
10/2012
1Biomarkers (Surrogate Marker)IBA
09/2012
1InterferonsIBA
06/2011
1HDL LipoproteinsIBA
03/2011
1ApoproteinsIBA
03/2011
1Apolipoprotein A-I (Apolipoprotein A1)IBA
03/2011
1HLA-G Antigens (HLA G)IBA
02/2011
1vasectrin IIIIBA
02/2011
1Interferon-gamma (Interferon, gamma)IBA
04/2009
1XenobioticsIBA
04/2008
1Cytochrome P-450 CYP2C19IBA
04/2008
1Cytochrome P-450 CYP2D6 (CYP2D6)IBA
04/2008
1Cytochrome P-450 CYP2E1 (CYP2E1)IBA
04/2008
1Matrix Metalloproteinase 1 (Interstitial Collagenase)IBA
09/2007
1Matrix Metalloproteinases (MMPs)IBA
09/2007
1Peptide Hydrolases (Proteases)FDA Link
09/2007
1isoleucylvalineIBA
05/2007
1aspartylglycineIBA
05/2007
1Nuclear Antigens (Extractable Nuclear Antigens)IBA
02/2006
1AutoantibodiesIBA
02/2006

Therapy/Procedure

2Aftercare (After-Treatment)
05/2011 - 04/2008
1Therapeutics
04/2008